DLG1 and depressive symptom measurement: In vivo, conditional knockout of microglial Dlg1 inhibited microglial activation, decreased inflammatory cytokine levels, and alleviated depression-like behaviors in mice, providing a potential therapeutic strategy to treat or slow down the progression of depression.